Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81 M Flint, C Maidens, LD Loomis-Price, C Shotton, J Dubuisson, P Monk, ... Journal of virology 73 (8), 6235-6244, 1999 | 623 | 1999 |
CD81 is required for hepatitis C virus glycoprotein-mediated viral infection J Zhang, G Randall, A Higginbottom, P Monk, CM Rice, JA McKeating Journal of virology 78 (3), 1448-1455, 2004 | 503 | 2004 |
Function, structure and therapeutic potential of complement C5a receptors PN Monk, AM Scola, P Madala, DP Fairlie British journal of pharmacology 152 (4), 429-448, 2007 | 501 | 2007 |
T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4⁺ T cells G Arbore, EE West, R Spolski, AAB Robertson, A Klos, C Rheinheimer, ... Science 352 (6292), aad1210, 2016 | 484 | 2016 |
Cxc chemokine receptor expression on human endothelial cells C Murdoch, PN Monk, A Finn Cytokine 11 (9), 704-712, 1999 | 343 | 1999 |
International union of basic and clinical pharmacology. LXXXVII. Complement peptide C5a, C4a, and C3a receptors A Klos, E Wende, KJ Wareham, PN Monk Pharmacological reviews 65 (1), 500-543, 2013 | 338 | 2013 |
The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg74 SA Cain, PN Monk Journal of Biological Chemistry 277 (9), 7165-7169, 2002 | 328 | 2002 |
Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2 A Higginbottom, ER Quinn, CC Kuo, M Flint, LH Wilson, E Bianchi, ... Journal of virology 74 (8), 3642-3649, 2000 | 324 | 2000 |
The concise guide to pharmacology 2017/18: overview SPH Alexander, E Kelly, NV Marrion, JA Peters, E Faccenda, SD Harding, ... British journal of pharmacology 174, S1-S16, 2017 | 310 | 2017 |
Endothelial adhesion receptors are recruited to adherent leukocytes by inclusion in preformed tetraspanin nanoplatforms O Barreiro, M Zamai, M Yanez-Mo, E Tejera, P Lopez-Romero, PN Monk, ... The Journal of cell biology 183 (3), 527-542, 2008 | 280 | 2008 |
Microglia as potential contributors to motor neuron injury in amyotrophic lateral sclerosis SA Sargsyan, PN Monk, PJ Shaw Glia 51 (4), 241-253, 2005 | 262 | 2005 |
Endothelial tetraspanin microdomains regulate leukocyte firm adhesion during extravasation O Barreiro, M Yáñez-Mó, M Sala-Valdés, MD Gutiérrez-López, S Ovalle, ... Blood 105 (7), 2852-2861, 2005 | 256 | 2005 |
The chemoattractant receptor-like protein C5L2 binds the C3a des-Arg77/acylation-stimulating protein D Kalant, SA Cain, M Maslowska, AD Sniderman, K Cianflone, PN Monk Journal of Biological Chemistry 278 (13), 11123-11129, 2003 | 249 | 2003 |
C5L2 is a functional receptor for acylation-stimulating protein D Kalant, R MacLaren, W Cui, R Samanta, PN Monk, SA Laporte, ... Journal of Biological Chemistry 280 (25), 23936-23944, 2005 | 244 | 2005 |
The concise guide to PHARMACOLOGY 2015/16: Overview SPH Alexander, E Kelly, N Marrion, JA Peters, HE Benson, E Faccenda, ... British journal of pharmacology 172 (24), 5729-5743, 2015 | 243 | 2015 |
Astrocyte function and role in motor neuron disease: a future therapeutic target? D Blackburn, S Sargsyan, PN Monk, PJ Shaw Glia 57 (12), 1251-1264, 2009 | 240 | 2009 |
Complement component 5a (c5a) HD Manthey, TM Woodruff, SM Taylor, PN Monk The international journal of biochemistry & cell biology 41 (11), 2114-2117, 2009 | 226 | 2009 |
STRO-1, HOP-26 (CD63), CD49a and SB-10 (CD166) as markers of primitive human marrow stromal cells and their more differentiated progeny: a comparative investigation in vitro K Stewart, P Monk, S Walsh, CM Jefferiss, J Letchford, JN Beresford Cell and tissue research 313, 281-290, 2003 | 198 | 2003 |
The human complement fragment receptor, C5L2, is a recycling decoy receptor AM Scola, KO Johswich, BP Morgan, A Klos, PN Monk Molecular immunology 46 (6), 1149-1162, 2009 | 183 | 2009 |
The complement factor C5a contributes to pathology in a rat model of amyotrophic lateral sclerosis TM Woodruff, KJ Costantini, JW Crane, JD Atkin, PN Monk, SM Taylor, ... The Journal of Immunology 181 (12), 8727-8734, 2008 | 170 | 2008 |